Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure

Hepatology ◽  
2018 ◽  
Vol 67 (5) ◽  
pp. 2049-2050
Author(s):  
Chetan Kalal ◽  
Akash Shukla ◽  
Ravi Mohanka ◽  
Mihir Vora ◽  
Priyesh Patel ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Virus Genotype ◽  
Genotype 1B

scholarly journals An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

Intervirology ◽  
2009 ◽  
Vol 52 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Hitomi Sezaki ◽  
Fumitaka Suzuki ◽  
Norio Akuta ◽  
Hiromi Yatsuji ◽  
Tetsuya Hosaka ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pilot Study ◽  
Pegylated Interferon ◽  
Virus Genotype ◽  
Viral Loads ◽  
Genotype 1B ◽  
Open Pilot

scholarly journals HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b

Medicine ◽  
2019 ◽  
Vol 98 (10) ◽  
pp. e14795
Author(s):  
Zhijuan Fan ◽  
Junfeng Liu ◽  
Fengmei Wang ◽  
Jingmin Liu ◽  
Xian Ding ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Core Antigen ◽  
Virus Genotype ◽  
Hcv Core Antigen ◽  
Genotype 1B
Sign in / Sign up

Export Citation Format

Share Document